Dime La VerDAD: Verify, Debunk, and Disseminate
Who can join
Ages 18 to 99 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: 1. 18 years or older 2. Fluent in English or Spanish 3. Provide services as a community health worker or similar designation in at least one of the seven communities with high morbidity and mortality due to respiratory virus infections 4. Have a social media presence (personal or work related) Exclusion Criteria: 1. Plan to stop working as a community health worker or similar designation before spring of 2028 (end of data collection planned) 2. Do not wish to participate in a social media campaign
About the study
Dime la Verdad (Tell me the truth) will evaluate the use of storytelling by community health workers as a communication strategy to disseminate reliable health information on social media and encourage informed decision-making in favor of recommended immunizations in communities with high morbidity and mortality due to respiratory virus infections.
Dime La Verdad is an innovative social media capacity-building program based on theoretical frameworks related to health communication that empowers community health workers to disseminate reliable information about respiratory virus protection strategies through the use of personal narratives on social media. The proposed work will use a rigorous stepped wedge design to 1) deliver a scalable program of science communicators using an adapted curriculum grounded in principles of health communication, 2) evaluate how diffusion of health messaging is perceived on social media, and 3) discern how use of personal narratives to enhance science communication can encourage informed decision-making to promote evidence-based immunization practices and improve health outcomes.
What is being tested
- Science Communication Curriculum Cohort 1 (behavioral)
- Science communication curriculum Cohort 2 (behavioral)
- Science communication curriculum Cohort 3 (behavioral)
- Science communication curriculum Cohort 4 (behavioral)
Sponsor: University of Chicago · Participants: 1,400 · Started: Jul 2, 2024
Contact the study team
- Yajaira Bolanos Flores, MPH · Phone: 773-571-0613
Official record on ClinicalTrials.gov — NCT06417762
Locations in the U.S.
| Illinois | University of Chicago, Chicago |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.